Global Health Limited (ASX:GLH)
0.0620
0.00 (0.00%)
May 1, 2026, 2:38 PM AEST
Global Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Revenue | 7.28 | 7.32 | 8.12 | 7.82 | 6.54 | 7.03 |
Other Revenue | 1.19 | 1.35 | 0.54 | - | - | - |
| 8.46 | 8.67 | 8.66 | 7.82 | 6.54 | 7.03 | |
Revenue Growth (YoY) | -5.50% | 0.08% | 10.75% | 19.61% | -7.01% | 12.48% |
Cost of Revenue | 6.48 | 6.57 | 6.12 | 7.31 | 6.6 | 5.6 |
Gross Profit | 1.98 | 2.1 | 2.54 | 0.51 | -0.06 | 1.43 |
Selling, General & Admin | 0.76 | 0.74 | 1.02 | 1.51 | 1.32 | 0.93 |
Research & Development | 1.86 | 2.1 | 2.69 | 2.21 | 0.31 | - |
Amortization of Goodwill & Intangibles | - | - | - | 0.48 | 0.28 | 0.41 |
Operating Expenses | 2.69 | 2.9 | 3.76 | 4.24 | 1.91 | 1.45 |
Operating Income | -0.71 | -0.8 | -1.23 | -3.73 | -1.98 | -0.01 |
Interest Expense | -0.14 | -0.11 | -0.03 | -0 | -0 | -0.01 |
Interest & Investment Income | 0.02 | 0.03 | 0.01 | 0 | 0 | 0 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.02 | -0.06 | -0.01 | -0 |
Other Non Operating Income (Expenses) | 0.02 | 0.02 | -0.05 | -0.01 | -0.03 | 0.39 |
EBT Excluding Unusual Items | -0.81 | -0.87 | -1.31 | -3.8 | -2.01 | 0.37 |
Asset Writedown | - | - | - | -3.9 | - | -1 |
Pretax Income | -0.81 | -0.87 | -1.31 | -7.7 | -2.01 | -0.63 |
Income Tax Expense | - | - | - | 0.35 | 0.04 | -0.14 |
Earnings From Continuing Operations | -0.81 | -0.87 | -1.31 | -8.05 | -2.05 | -0.49 |
Net Income | -0.81 | -0.87 | -1.31 | -8.05 | -2.05 | -0.49 |
Net Income to Common | -0.81 | -0.87 | -1.31 | -8.05 | -2.05 | -0.49 |
Shares Outstanding (Basic) | 59 | 58 | 58 | 58 | 56 | 42 |
Shares Outstanding (Diluted) | 59 | 58 | 58 | 58 | 56 | 42 |
Shares Change (YoY) | 0.78% | 0.27% | 0.92% | 2.71% | 32.20% | 8.50% |
EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.14 | -0.04 | -0.01 |
EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.14 | -0.04 | -0.01 |
Free Cash Flow | -0.32 | -0.71 | -1.15 | -3.47 | -1.19 | 1.37 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.06 | -0.02 | 0.03 |
Gross Margin | 23.39% | 24.21% | 29.31% | 6.54% | -0.99% | 20.39% |
Operating Margin | -8.37% | -9.25% | -14.15% | -47.70% | -30.23% | -0.16% |
Profit Margin | -9.56% | -10.00% | -15.15% | -103.03% | -31.35% | -6.94% |
Free Cash Flow Margin | -3.79% | -8.15% | -13.29% | -44.40% | -18.21% | 19.50% |
EBITDA | -0.7 | -0.79 | -1.22 | -3.72 | -1.97 | 0 |
EBITDA Margin | -8.25% | -9.15% | -14.09% | -47.63% | -30.18% | 0.01% |
D&A For EBITDA | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.01 |
EBIT | -0.71 | -0.8 | -1.23 | -3.73 | -1.98 | -0.01 |
EBIT Margin | -8.37% | -9.25% | -14.15% | -47.70% | -30.23% | -0.16% |
Revenue as Reported | 8.48 | 8.7 | 8.67 | 7.82 | 6.54 | 7.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.